Longboard Pharmaceuticals

Youtube Subscribe

Open: 9.84 Close: 8.72 Change: -1.12

The unbelievably easy way to evaluate Longboard Pharmaceuticals: Use an AI.

Are looking for the most relevant information about Longboard Pharmaceuticals? Investor spend a lot of time searching for information to make investment decisions in Longboard Pharmaceuticals. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Longboard Pharmaceuticals are: Longboard, Pharmaceuticals, NASDAQLBPH, issue, year, Get, Rating, and the most common words in the summary are: therapeutic, pharmaceutical, pharma, longboard, bioscience, biopharma, biotech, . One of the sentences in the summary was: FMR LLC increased its stake in Longboard. Other searches related to …

Concept Map

Semantic Network

Stock Summary

Longboard Pharmaceuticals, Inc. focuses on developing novel and transformative medicines for neurological diseases. Its lead product candidate is LP352, which is in Phase 1b/2a clinical trial for the treatment of seizures associated with developmental and epile.

Today's Summary

Longboard Pharmaceuticals (NASDAQ:LBPH – Get Rating ) – Wedbush issued their Q1 2024 earnings estimates for shares of Longboard pharmaceuticals in a note issued to investors on Wednesday, May 10th. FMR LLC increased its stake in Longboard. Pharmaceuticals has a 1-year low of $2.70 and a 1 year high of $10.29. Longboard Pharmaceuticals (NASDAQ:LBPH) stock is up 112% in the last year, providing strong gains for shareholders. As at March 2023, Longboard. Pharmaceuticals had cash of US$76m and no debt.

Today's News

Longboard Pharmaceuticals (NASDAQ:LBPH – Get Rating ) – Wedbush issued their Q1 2024 earnings estimates for shares of Longboard pharmaceuticals in a note issued to investors on Wednesday, May 10th. FMR LLC increased its stake in Longboard. Pharmaceuticals has a 1-year low of $2.70 and a 1 year high of $10.29. Longboard Pharmaceuticals (NASDAQ:LBPH) stock is up 112% in the last year, providing strong gains for shareholders. As at March 2023, Longboard. Pharmaceuticals had cash of US$76m and no debt.

Stock Profile

"Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel and transformative medicines for neurological diseases. Its lead product candidate is LP352, which is in Phase 1b/2a clinical trial for the treatment of seizures associated with developmental and epileptic encephalopathies. The company's preclinical product candidate includes LP659 which focuses on developing therapies for multiple neurological diseases; and LP143. It also entered into license agreement with Arena Pharmaceuticals Inc. to develop and commercialize LP352, LP659, LP143, and other compounds. The company was formerly known as Arena Neuroscience, Inc. and changed its name to Longboard Pharmaceuticals, Inc. in October 2020. Longboard Pharmaceuticals, Inc. was incorporated in 2020 and is based in La Jolla, California."

Keywords

This document will help you to evaluate Longboard Pharmaceuticals without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Longboard Pharmaceuticals are: Longboard, Pharmaceuticals, NASDAQLBPH, issue, year, Get, Rating, and the most common words in the summary are: therapeutic, pharmaceutical, pharma, longboard, bioscience, biopharma, biotech, . One of the sentences in the summary was: FMR LLC increased its stake in Longboard. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #therapeutic #pharmaceutical #pharma #longboard #bioscience #biopharma #biotech.

Read more →

Youtube Subscribe

---